Walleye Capital’s Pulmonx LUNG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-372,290
Closed -$3.85M 5271
2023
Q3
$3.85M Buy
+372,290
New +$4.31M 0.01% 1227
2022
Q4
Sell
-27,559
Closed -$459K 3443
2022
Q3
$459K Sell
27,559
-6,498
-19% -$120K 0.01% 1539
2022
Q2
$501K Buy
+34,057
New +$702K 0.01% 1027
2021
Q4
Sell
-8,154
Closed -$293 2221
2021
Q3
$293 Buy
+8,154
New +$321K 0.01% 1023

Other funds holding LUNG

Walleye Capital's LUNG Position: Q4 2023 in Review

Walleye Capital sold out of Pulmonx (LUNG) in Q4 2023, closing a stake of 372,290 shares — an estimated $3.85M sold.

Walleye Capital first reported a position in LUNG in Q3 2021 and held it in 4 quarters. The position peaked at $3.85M in Q3 2023. 123 funds tracked by Wall St. Rank hold LUNG as of Q4 2023.

  • Walleye Capital reported no remaining Pulmonx position as of Q4 2023 after selling out during the quarter.
  • Walleye Capital sold 372,290 Pulmonx shares in Q4 2023, an estimated $3.85M.
  • Walleye Capital first reported a position in Pulmonx in Q3 2021 and held it in 4 quarters.
  • Walleye Capital's Pulmonx position peaked at $3.85M in Q3 2023.
  • 123 funds tracked by Wall St. Rank held Pulmonx as of Q4 2023.

Based on Walleye Capital's 13F filing for Q4 2023, filed 14 Feb 2024.